PRNHX (PRNHX) Stock Price & Analysis
PRNHX (PRNHX) fell 1.04% to USD 57.37 as of July 26, 2026 at 00:26 UTC, according to Nexqual real-time market data.
PRNHX last closed at USD 57.97; the session ranged USD 57.37–57.37 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.95–61.64 (NAS). Source: Nexqual, July 26, 2026 at 00:26 UTC.
Key Statistics (as of July 26, 2026 at 00:26 UTC)
| Price | USD 57.37 |
|---|---|
| Change | ▼ 1.04% (down) |
| Previous Close | USD 57.97 |
| Open | USD 57.37 |
| Day Range | USD 57.37 – 57.37 |
| 52-Week Range | USD 48.95 – 61.64 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (PRNHX)
Nexqual's technical model rates PRNHX "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 00:26 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.16 (neutral) |
| vs SMA50 | Below (USD 58.65) |
| MACD | -0.31 (negative) |
Financial Health Score (PRNHX)
Nexqual rates PRNHX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 00:26 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRHSX | T. Rowe Price Health Sciences F | USD 90.29 | ▲ 1.27% |
| RPMGX | T. Rowe Price Mid-Cap Growth Fu | USD 98.52 | ▼ 0.53% |
| PRFDX | T. Rowe Price Equity Income Fd | USD 44.73 | ▲ 0.22% |
| PRSCX | T. Rowe Price Science and Techn | USD 68.7 | ▼ 2.54% |
| PRGFX | T. Rowe Price Growth Stock Fd | USD 106.27 | ▼ 2.47% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 00:26 UTC. This page is informational and not investment advice.